Sarepta says it will continue to ship Elevidys despite FDA requests that it stop shipments of the Duchenne muscular dystrophy gene therapy, while Verizon tops earnings expectation and raises 2025 ...

Benchmark analyst Mickey Legg initiated coverage of shares of the auto maker with a Buy rating and $65 price target.

U.S. stocks edged higher Monday as investors awaited key earnings. Domino’s and Verizon surged after posting stronger-than-expected results.